Indivumed

Indivumed was founded in 2002 by leading scientists with the mission to revolutionize cancer treatment through personalized therapies. As an integrated global oncology company led by physicians, their experts utilize the world’s leading multi-omics oncology database and the highest-quality biobank to map the true landscape of cancer. Their three divisions operate holistically to generate, characterize, and analyze biospecimens from human cancer patients. Indivumed is headquartered in Hamburg, Germany, with a subsidiary and global clinical network in the United States.